Our Focus Areas
Do you need a new pharmacovigilance system? Is your instance of Oracle Argus fully compliant? Are your adverse event workflows sound? We specialize in helping life sciences innovators get the most out of their PV investment and ensure patient safety.Learn More
Mergers, Acquisitions & Divestitures
Whether you’re preparing a company for sale or absorbing massive amounts of content after M&A activity, we can help ensure seamless operations and compliance with 21 CFR Part 11 and other relevant regulations.Learn More
Our team has deep experience helping R&D teams interface more cleanly and efficiently with FDA, EMA and other regulatory bodies. We’ve implemented dozens of submission systems, publishing systems and registration systems.Learn More
Working Exclusively With Life Sciences
At Daelight Solutions, we believe the only path to success is attracting and empowering talented, dedicated people to deliver real-world outcomes for our clients. That philosophy, combined with a laser focus on Life Sciences, has made us an employer of choice for subject matter experts and strategists in our field.
Combined Years in Life Sciences
"Simply put, our engagements with Daelight have proved more valuable than the work we've done with some of the 'big' consulting firms. They care about results."
"Daelight provides something different than most consultants. They think strategically, but they're not afraid to get their hands dirty and get things done."
"The most important thing about Daelight is that we know we can trust them to keep their word. That means a lot when the stakes are high."
From The Blog
Are You Thinking About Pharmacovigilance Inspection Readiness?
Pharmacovigilance (PV) inspections are increasingly challenging, whether in small start-ups with limited resources or in big pharma organizations with complex contractual arrangements and diverse products. From process and documentation to PV systems and tools, you must be ready to address detailed inspection requests from regulatory authorities across the globe.